{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:40:07Z","timestamp":1769168407658,"version":"3.49.0"},"reference-count":10,"publisher":"Japanese Urological Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2018,4,20]]},"DOI":"10.5980\/jpnjurol.109.106","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T22:05:08Z","timestamp":1555625108000},"page":"106-110","source":"Crossref","is-referenced-by-count":2,"title":["A CASE OF MALIGNANT PARAGANGLIOMA OF THE URINARY BLADDER TREATED WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND DACARBAZINE CHEMOTHERAPY AND METAIODOBENZYLGUANIDINE THERAPY","\u8180\u80f1\u306b\u767a\u751f\u3057\u305f\u60aa\u6027\u30d1\u30e9\u30ac\u30f3\u30b0\u30ea\u30aa\u30fc\u30de\u306b\u5bfe\u3057CVD\u7642\u6cd5\u3068MIBG\u5185\u7167\u5c04\u6cbb\u7642\u3092\u65bd\u884c\u3057\u305f\u4e00\u4f8b"],"prefix":"10.5980","volume":"109","author":[{"given":"Yushi","family":"Yamauchi","sequence":"first","affiliation":[{"name":"Department of Urology, Japanese Red Cross Nagoya Daini Hospital"},{"name":"Department of Urology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Matsukawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Urology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Urology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokunori","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Urology, Japanese Red Cross Nagoya Daini Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momokazu","family":"Gotoh","sequence":"additional","affiliation":[{"name":"Department of Urology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Zimmerman IJ, Biron RE and MacMahon HE: Pheochromocytoma of the urinary bladder. N Engl J Med, 249, 25-26, 1953.","DOI":"10.1056\/NEJM195307022490106"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Amar L, Baudin E, Burnichon N, Peyrard S, Silcera S, Bertagna X, Schlumberger M and Plouin PF: Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas. Jclin Endocrinol Metab, 92 (10), 3822-3828, 2007.","DOI":"10.1210\/jc.2007-0709"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Maeda M, Funahashi T, Katoh M, Fujita T, Tsuruta K and Gotoh M: Malignant Bladder Pheochromocytoma with SDHB Genetic Mutation. Aktuel Urol, 44 (05), 381-382, 2013.","DOI":"10.1055\/s-0033-1345147"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Linda Ng and Libertino JM: Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol, 169, 5-11, 2003.","DOI":"10.1016\/S0022-5347(05)64023-2"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Amar L, Baudin E, Burnichon N, Peyrard S, Silvera S, Bertherat J and Bertagna X: Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas. J Clin Endocrinol Metab, 92, 3822-3828, 2007.","DOI":"10.1210\/jc.2007-0709"},{"key":"6","doi-asserted-by":"crossref","unstructured":"8) Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiglia F, Fassnacht M and Pentheroudakis G: Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann oncol, 23, 131-138, 2012.","DOI":"10.1093\/annonc\/mds231"},{"key":"7","doi-asserted-by":"crossref","unstructured":"9) Mishra A, Agarwal G, Kapoor A, Agarwal A and Bhatia E: Catecholamine cardiomyopathy in bilateral malignant pheochromocytomay. Int J cardiol, 76, 89-90, 2000.","DOI":"10.1016\/S0167-5273(00)00363-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"11) Loh KC, Fitzgerald PA, Matthay KK, Yeo P and Prince DC: The treatment of malignant pheochromocytoma with iodine-131 MIBG: a comprehensive review of 116 reported patients. J Endocrinol Invest, 20, 648-658, 1997.","DOI":"10.1007\/BF03348026"},{"key":"9","doi-asserted-by":"publisher","unstructured":"12) Huang H, Abraham J, Hung E, Averbuch S, Merino M and Fojo T: Treatment of malignant pheochromocytoma\/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients. Cancer, 113 (8), 2020-8, 2008.","DOI":"10.1002\/cncr.23812"},{"key":"10","doi-asserted-by":"crossref","unstructured":"13) Safford SD, Coleman RE, Gockerman JP, Moore J, Feldman JM, Leight GS and Tyler DS: Iodine-131 MIBG is an effective treatment for malignant pheochromocytoma and paraganglioma. Surgery, 134, 956-962, 2003.","DOI":"10.1016\/S0039-6060(03)00426-4"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/2\/109_106\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T03:44:38Z","timestamp":1555731878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/2\/109_106\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.109.106","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]}}}